Mixed Verdicts for Merck in Vioxx Cases
80437
A New Jersey jury ruled that Merck failed to provide adequate warning about the risks of its Vioxx painkiller in one of two cases decided.
654583
A Tennessee man's claim that the maker of the painkiller Vioxx should be blamed for his 2003 heart attack was rejected yester day by a federal jury, the fourth victory for Merck &amp; Co. in five federal trials.
621270
A medical officer responsible for evaluating Vioxx testified that there were preliminary indications of heart problems with the painkiller, but it was difficult to sort through conflicting data.
528247
BIRMINGHAM, Alabama  - An Alabama state court jury on Friday handed Merck & Co.  its second victory this week in a Vioxx product liability trial, finding that the drugmaker did not hide the health risks associated with its withdrawn arthritis drug.
370583
The $50 million compensatory damage award in a federal Vioxx case this month was "grossly excessive," and a new trial must be held to decide how much drugmaker Merck &amp; Co. must pay a retired FBI agent who suffered a heart attack after taking the painkiller, a federal judge ruled Wednesday.
643833
NEW YORK - Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck &amp; Co. must now contend with hundreds of lawsuits over the drug&#39;s side effects - lawsuits that threaten to further damage the company&#39;s finances and reputation.
740825
ATLANTIC CITY, New Jersey  - Merck & Co.  failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but gave adequate warning in another, a New Jersey jury found on Friday in a split decision in two suits tried simultaneously.
200299
The recall of Vioxx--an arthritis treatment taken by millions of people--is a disaster for everyone. Of course it&#39;s bad news for Merck (nyse: MRK - news - people), the drug&#39;s maker.
132890
Rival drug giants Pfizer Inc.  and Merck & Co. Inc.  argued conflicting views of the dangers of their pain relievers on Wednesday to U.S. science advisers weighing the risks of medicines similar to recalled arthritis drug Vioxx.
10458
NEW YORK - Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck &amp; Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market.
60462
A New Orleans jury handed Merck & Co. a victory Wednesday in the latest federal Vioxx product liability trial, finding that the drugmaker adequately warned of the heart risks associated with the medicine.
560620
Patients taking Merck & Co.'s Vioxx arthritis drug had 50 percent more heart attacks and cases of sudden cardiac death than those taking Pfizer Inc.'s rival Celebrex drug, according to a large study financed by the U.S. Food and Drug Administration.
625984
Merck and Co  on Wednesday reported a fourth-quarter loss due to charges from a costly settlement related to its withdrawn Vioxx arthritis drug, but results soundly beat Wall Street forecasts and lifted its shares 2 percent.
569961
By Rosie Murray-West, City Correspondent (Filed: 01/10/2004). US pharmaceutical giant Merck lost about a quarter of its value yesterday after it pulled arthritis drug Vioxx owing to concerns over heart attacks as a side-effect.
217282
A federal jury on Thursday found  that Merck & Co. Inc. was negligent and knowingly made  misrepresentations about its withdrawn pain medicine Vioxx, and  awarded $51 million to the plaintiff.
361997
Merck and Co  on Wednesday reported a fourth-quarter loss due to a number of charges, including for a costly settlement related to its withdrawn Vioxx arthritis drug.
155261
A U.S. judge in New Orleans threw out a Vioxx victory for Merck, citing misrepresentation by a key company witness and clearing the way for a third trial in the case of a widow who charges that the painkiller caused her husband's fatal heart attack.